Corrigendum to “A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer” [Bioorgan. Chem. 119 (2022) 105505] (10.1016/j.bioorg.2021.105505)

Svenja Lier, Andreas Sellmer, Felix Orben, Stephanie Heinzlmeir, Lukas Krauß, Christian Schneeweis, Zonera Hassan, Carolin Schneider, Arlette Schäfer, Herwig Pongratz, Thomas Engleitner, Rupert Öllinger, Anna Kuisl, Florian Bassermann, Christoph Schlag, Bo Kong, Stefan Dove, Bernhard Kuster, Roland Rad, Maximilian ReichertMatthias Wirth, Dieter Saur, Siavosh Mahboobi, Günter Schneider

Research output: Contribution to journalComment/debate

Abstract

The original article reports the structure of MDEG-541. Regrettably, Figure 1A contains an inaccurately depicted chemical structure due to an error. The correct structure of MDEG-541 is shown below.[Formula presented] This error does not affect the conclusions of the manuscript, since the correct compound was used in all experiments. We deeply regret the error and apologize for any confusion the error may have caused.

Original languageEnglish
Article number107248
JournalBioorganic Chemistry
Volume146
DOIs
StatePublished - May 2024

Fingerprint

Dive into the research topics of 'Corrigendum to “A novel Cereblon E3 ligase modulator with antitumor activity in gastrointestinal cancer” [Bioorgan. Chem. 119 (2022) 105505] (10.1016/j.bioorg.2021.105505)'. Together they form a unique fingerprint.

Cite this